Business Description
Astrana Health Inc
NAICS : 621999
SIC : 8099
ISIN : US03763A2078
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.92 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.52 | |||||
Debt-to-EBITDA | 2.6 | |||||
Interest Coverage | 5.25 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.48 | |||||
Beneish M-Score | -2.49 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 44 | |||||
3-Year EBITDA Growth Rate | 49.2 | |||||
3-Year FCF Growth Rate | -11 | |||||
3-Year Book Growth Rate | 18.8 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 41.81 | |||||
9-Day RSI | 37.45 | |||||
14-Day RSI | 38.55 | |||||
6-1 Month Momentum % | 34.54 | |||||
12-1 Month Momentum % | 18.32 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.11 | |||||
Quick Ratio | 2.11 | |||||
Cash Ratio | 1.36 | |||||
Days Sales Outstanding | 38.8 | |||||
Days Payable | 3.28 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.5 | |||||
Shareholder Yield % | -1.45 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 15.5 | |||||
Operating Margin % | 6.1 | |||||
Net Margin % | 4.38 | |||||
FCF Margin % | 2.86 | |||||
ROE % | 10.55 | |||||
ROA % | 6.08 | |||||
ROIC % | 8.12 | |||||
ROC (Joel Greenblatt) % | 86.31 | |||||
ROCE % | 13.01 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 28.82 | |||||
PE Ratio without NRI | 27.62 | |||||
Shiller PE Ratio | 168.98 | |||||
Price-to-Owner-Earnings | 53.99 | |||||
PEG Ratio | 3.41 | |||||
PS Ratio | 1.25 | |||||
PB Ratio | 2.84 | |||||
Price-to-Tangible-Book | 6.6 | |||||
Price-to-Free-Cash-Flow | 43.65 | |||||
Price-to-Operating-Cash-Flow | 25.42 | |||||
EV-to-EBIT | 16.16 | |||||
EV-to-EBITDA | 13.84 | |||||
EV-to-Revenue | 1.23 | |||||
EV-to-FCF | 43.15 | |||||
Price-to-Projected-FCF | 2.08 | |||||
Price-to-Median-PS-Value | 1.05 | |||||
Price-to-Graham-Number | 2.85 | |||||
Price-to-Net-Current-Asset-Value | 12.24 | |||||
Earnings Yield (Greenblatt) % | 6.19 | |||||
FCF Yield % | 2.35 |